Cargando…
Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase
Targeted gene therapy strategies utilizing homology-driven repair (HDR) allow for greater control over transgene integration site, copy number, and expression—significant advantages over traditional vector-mediated gene therapy with random genome integration. However, the relatively low efficiency o...
Autores principales: | Paul, Biswajit, Ibarra, Guillermo S. Romano, Hubbard, Nicholas, Einhaus, Teresa, Astrakhan, Alexander, Rawlings, David J., Kiem, Hans-Peter, Peterson, Christopher W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054698/ https://www.ncbi.nlm.nih.gov/pubmed/30038938 http://dx.doi.org/10.1016/j.omtm.2018.04.002 |
Ejemplares similares
-
Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance
por: Romano Ibarra, Guillermo S, et al.
Publicado: (2016) -
Tales of Dihydrofolate Binding to R67 Dihydrofolate
Reductase
por: Duff, Michael R., et al.
Publicado: (2015) -
Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates
por: Murray, Jason, et al.
Publicado: (2023) -
Adaptations for Pressure and Temperature in Dihydrofolate Reductases
por: Penhallurick, Ryan W., et al.
Publicado: (2021) -
Efficient Selection of Genetically Modified Human T Cells Using Methotrexate-Resistant Human Dihydrofolate Reductase
por: Jonnalagadda, Mahesh, et al.
Publicado: (2013)